Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 111911 | Tariquidar | 206873-63-4 | 98% |  |
| Tariquidar is a P-glycoprotein inhibitor undergoing research as an adjuvant against m | ||||
| 111009 | TBPB | 634616-95-8 | 98% |  |
| TBPB is an allosteric M1 mAChR agonist(EC50=289 nM) that regulates amyloid processing | ||||
| 110228 | Tubastatin A HCl | 1310693-92-5 | 96% |  |
| Tubastatin A is a potent and selective HDAC6 inhibitor. Demonstrates 1093-fold select | ||||
| 110226 | TG003 | 300801-52-9 | 98% |  |
| TG003 is a novel benzothiazole compound that demonstrates potent inhibition of Clk1/S | ||||
| 110225 | Tubastatin A | 1252003-15-8 | 98% |  |
| Tubastatin A is a potent HDAC6 inhibitor with an IC50 value of 15 nM. Comparatively, | ||||
| 110213 | tert-Butyl 3-oxoazetidine-1-carboxylate | 398489-26-4 | 98% |  |
| Coming soon! | ||||
| 110202 | tert-butyl N-(6-methylpyridin-3-yl)carbamate | 323578-37-6 | 98% | carbamate-cas-323578-37-6.png) |
| Coming soon! | ||||
| 102910 | T-807( AV1451) | 1415379-56-4 | 98% |  |
| T807( AV1451) is a novel tau positron emission tomography imaging agent for Alzheimer | ||||
| 102909 | THK-5107 | 1374107-54-6 | 98% |  |
| Coming soon! | ||||
| 102906 | THK5105 | 1374107-64-8 | 98% | |
| Coming soon! | ||||
| 102905 | THK-523 | 1573029-17-0 | 98% | |
| Coming soon! | ||||
| 101904 | TAS-103 dihydrochloride | 174634-09-4 | 98% |  |
| TAS-103, also known as BMS-247615, is a quinoline derivative that displays antitumor | ||||
| 101207 | TP-0903(Dubermatinib) | 1341200-45-0 | 98% |  |
| TP-0903 is a potent and selective Axl kinase inhibitor with IC50 of 27 nM. | ||||
| 101205 | Temsirolimus | 162635-04-3 | 98% |  |
| Temsirolimus is a recently developed mTOR inhibitor. with improved aqueous solubility | ||||
| 101001 | 1,3,5-TRIBROMO-2,4,6-TRIMETHYL-BENZENE | 608-72-0 | 98% |  |
| Coming soon! | ||||
| 100906 | Tretazicar (CB1954) | 21919-05-1 | 98% | -cas-21919-05-1.png) |
| Tretazicar is a dinitrobenzamide prodrug that is converted in the presence of the enz | ||||
| 92217 | TP808 | 852821-06-8 | 98% | |
| Coming soon! | ||||
| 92216 | TP-434 | 1207283-85-9 | 98% |  |
| Coming soon! | ||||
| 91833 | Teriflunomide | 108605-62-5 | 98% |  |
| Teriflunomide is the active metabolite of leflunomide which is an immunomodulatory dr | ||||
| 91832 | tert-butyl 3,3-dimethyl-4-oxopiperidine-1-carboxylate | 324769-06-4 | 98% |  |
| Coming soon! | ||||
| 91825 | TsDACH RuCl(p-cymene) | 192057-12-8 | 98% | |
| Coming soon! | ||||
| 91701 | trimethyl-[2-[[4-(1H-pyrazol-4-yl)pyrrolo[2,3-d]pyrimidin-7-yl]methoxy]ethyl]silane | 941685-27-4 | 98% | pyrrolo[23-d]pyrimidin-7-yl]methoxy]ethyl]silane-cas-941685-27-4.png) |
| Coming soon! | ||||
| 90732 | Taselisib(GDC-0032) | 1282512-48-4 | 98% by HPLC | -cas-1282512-48-4.png) |
| GDC-0032 (RG7604) is a small molecule PI3 kinase inhibitor. PI3 Kinase is an oncogene | ||||
| 90704 | 3-[4-(Trifluoromethyl)phenyl]propionic Acid | 53473-36-2 | 98% | phenyl]propionicAcid-cas-53473-36-2.png) |
| Coming soon! | ||||
| 90701 | 3-(4-(tert-Butyl)phenyl)propanoic acid | 1208-64-6 | 98% | phenyl)propanoicacid-cas-1208-64-6.png) |
| Coming soon! | ||||
| 90620 | 3-(3,4,5-Trifluorophenyl)propanoic acid | 886499-50-9 | 98% | propanoicacid-cas-886499-50-9.png) |
| Coming soon! | ||||
| 90115 | tert-butyl ((3S,5S)-5-(hydroxymethyl)pyrrolidin-3-yl)carbamate hydrochloride | 1217680-19-7 | 98% | -5-(hydroxymethyl)pyrrolidin-3-yl)carbamatehydrochloride-cas-1217680-19-7.png) |
| Coming soon! | ||||
| 90106 | tert-butyl N-[4-(methylamino)butyl]carbamate,hydrochloride | 1188263-77-5 | 98% | butyl]carbamatehydrochloride-cas-1188263-77-5.png) |
| Coming soon! | ||||
| 90105 | tert-butyl N-(4-aminobutyl)carbamate,hydrochloride | 33545-98-1 | 98% | carbamatehydrochloride-cas-33545-98-1.png) |
| Coming soon! | ||||
| 83129 | tert-butyl (3S)-3-cyanopyrrolidine-1-carboxylate | 132945-78-9 | 98% | -3-cyanopyrrolidine-1-carboxylate-cas-132945-78-9.png) |
| Coming soon! | ||||